Recent Finacing
Recent Raise
SeQure Dx commercializes licensed GUIDE‑seq and ONE‑seq assays and operates a full‑service laboratory providing off‑target gene‑editing analysis for drug development, clinical trials, and pre‑therapy patient evaluation.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at SeQure Dx.
